Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 57

1.

Coxiella burnetii modulates Beclin 1 and Bcl-2, preventing host cell apoptosis to generate a persistent bacterial infection.

Vázquez CL, Colombo MI.

Cell Death Differ. 2010 Mar;17(3):421-38. doi: 10.1038/cdd.2009.129.

2.

Actin dynamics and Rho GTPases regulate the size and formation of parasitophorous vacuoles containing Coxiella burnetii.

Aguilera M, Salinas R, Rosales E, Carminati S, Colombo MI, Berón W.

Infect Immun. 2009 Oct;77(10):4609-20. doi: 10.1128/IAI.00301-09.

3.

The macrophage marches on its phagosome: dynamic assays of phagosome function.

Russell DG, Vanderven BC, Glennie S, Mwandumba H, Heyderman RS.

Nat Rev Immunol. 2009 Aug;9(8):594-600. doi: 10.1038/nri2591.

4.

Antibody-mediated immunity to the obligate intracellular bacterial pathogen Coxiella burnetii is Fc receptor- and complement-independent.

Shannon JG, Cockrell DC, Takahashi K, Stahl GL, Heinzen RA.

BMC Immunol. 2009 May 8;10:26. doi: 10.1186/1471-2172-10-26.

5.

Host cell-free growth of the Q fever bacterium Coxiella burnetii.

Omsland A, Cockrell DC, Howe D, Fischer ER, Virtaneva K, Sturdevant DE, Porcella SF, Heinzen RA.

Proc Natl Acad Sci U S A. 2009 Mar 17;106(11):4430-4. doi: 10.1073/pnas.0812074106.

6.

Sustained activation of Akt and Erk1/2 is required for Coxiella burnetii antiapoptotic activity.

Voth DE, Heinzen RA.

Infect Immun. 2009 Jan;77(1):205-13. doi: 10.1128/IAI.01124-08.

7.

Cathepsin D: a cellular roadmap.

Zaidi N, Maurer A, Nieke S, Kalbacher H.

Biochem Biophys Res Commun. 2008 Nov 7;376(1):5-9. doi: 10.1016/j.bbrc.2008.08.099. Review.

PMID:
18762174
8.

Ankyrin repeat proteins comprise a diverse family of bacterial type IV effectors.

Pan X, Lührmann A, Satoh A, Laskowski-Arce MA, Roy CR.

Science. 2008 Jun 20;320(5883):1651-4. doi: 10.1126/science.1158160.

9.

The uptake of apoptotic cells drives Coxiella burnetii replication and macrophage polarization: a model for Q fever endocarditis.

Benoit M, Ghigo E, Capo C, Raoult D, Mege JL.

PLoS Pathog. 2008 May 16;4(5):e1000066. doi: 10.1371/journal.ppat.1000066.

10.

Infection of human monocyte-derived macrophages with Coxiella burnetii.

Shannon JG, Heinzen RA.

Methods Mol Biol. 2008;431:189-200.

PMID:
18287757
11.

A method for purifying obligate intracellular Coxiella burnetii that employs digitonin lysis of host cells.

Cockrell DC, Beare PA, Fischer ER, Howe D, Heinzen RA.

J Microbiol Methods. 2008 Mar;72(3):321-5. doi: 10.1016/j.mimet.2007.12.015.

12.

Securinine, a GABAA receptor antagonist, enhances macrophage clearance of phase II C. burnetii: comparison with TLR agonists.

Lubick K, Radke M, Jutila M.

J Leukoc Biol. 2007 Nov;82(5):1062-9. Erratum in: J Leukoc Biol. 2008 Apr;83(4):1068.

PMID:
17698917
13.

Lysosomes: fusion and function.

Luzio JP, Pryor PR, Bright NA.

Nat Rev Mol Cell Biol. 2007 Aug;8(8):622-32. Review.

PMID:
17637737
14.
15.

Efficient method of cloning the obligate intracellular bacterium Coxiella burnetii.

Beare PA, Howe D, Cockrell DC, Heinzen RA.

Appl Environ Microbiol. 2007 Jun;73(12):4048-54.

16.
17.

Lounging in a lysosome: the intracellular lifestyle of Coxiella burnetii.

Voth DE, Heinzen RA.

Cell Microbiol. 2007 Apr;9(4):829-40. Review.

PMID:
17381428
18.
19.

The autophagic pathway is actively modulated by phase II Coxiella burnetii to efficiently replicate in the host cell.

Romano PS, Gutierrez MG, Berón W, Rabinovitch M, Colombo MI.

Cell Microbiol. 2007 Apr;9(4):891-909.

PMID:
17087732
20.

Mycobacterium tuberculosis subverts innate immunity to evade specific effectors.

Loeuillet C, Martinon F, Perez C, Munoz M, Thome M, Meylan PR.

J Immunol. 2006 Nov 1;177(9):6245-55.

Items per page

Supplemental Content

Support Center